Eli Lilly

=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-06-15 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: ELI LILLY & Co (LLY) CIK: 0000059478 --- Reporting Owner --- Name: Sulzberger Gabrielle CIK: 0001262388 Role: Director --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-06-15 | Code: A (Grant or award) Shares: +4.3904 | Price: $1,129.35 Total Value: $4,958.30 Shares Owned After: 2,995.3956 | Ownership: D (Direct) Footnotes: [F1] At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. --- Footnotes (Complete Index) --- F1: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. --- Signature --- /s/ /s/ Jonathan Groff for Gabrielle Sulzberger, pursuant to authorization on file (2026-06-16)